Suppr超能文献

CD46中与腺病毒相互作用区域的定位。

Localization of regions in CD46 that interact with adenovirus.

作者信息

Gaggar Anuj, Shayakhmetov Dmitry M, Liszewski M Kathryn, Atkinson John P, Lieber André

机构信息

University of Washington School of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.

出版信息

J Virol. 2005 Jun;79(12):7503-13. doi: 10.1128/JVI.79.12.7503-7513.2005.

Abstract

A variety of pathogens use CD46, a ubiquitously expressed membrane protein that regulates complement activation, as a cellular attachment receptor. While the CD46 binding sites of several pathogens, including measles virus, Neisseria gonorrhea, and human herpesvirus 6, have been described, the region of CD46 responsible for adenovirus binding has not been determined. In this study, we used competition experiments with known CD46 ligands, CD46-specific antibodies, and a set of CD46 mutants to localize the binding domain for the group B adenovirus serotype 35 (Ad35). Our results show that Ad35 competes with measles virus for binding to CD46 but not with complement protein C3b. We further show that this interaction is a protein-protein interaction and that N glycosylations do not critically contribute to infection with Ad35 fiber-containing Ad vectors. Our data demonstrate that the native conformation of the CCP2 domain is crucial for Ad35 binding and that the substitution of amino acids at positions 130 to 135 or 152 to 156 completely abolishes the receptor function of CD46. These regions localize to the same planar face of CD46 and likely form an extended adenovirus binding surface, since no single amino acid substitution within these areas eliminates virus binding. Finally, we demonstrate that the infection with a virus possessing human group B serotype Ad11 fibers is also mediated by the CCP2 domain. This information is important to better characterize the mechanisms of the receptor recognition by adenovirus relative to other pathogens that interact with CD46, and it may help in the design of antiviral therapeutics against adenovirus serotypes that use CD46 as a primary cellular attachment receptor.

摘要

多种病原体将CD46(一种普遍表达且调节补体激活的膜蛋白)用作细胞附着受体。虽然已经描述了包括麻疹病毒、淋病奈瑟菌和人类疱疹病毒6在内的几种病原体的CD46结合位点,但负责腺病毒结合的CD46区域尚未确定。在本研究中,我们使用与已知CD46配体、CD46特异性抗体以及一组CD46突变体的竞争实验,来定位B组35型腺病毒(Ad35)的结合结构域。我们的结果表明,Ad35与麻疹病毒竞争结合CD46,但不与补体蛋白C3b竞争。我们进一步表明,这种相互作用是一种蛋白质-蛋白质相互作用,并且N-糖基化对含Ad35纤维的腺病毒载体感染没有关键作用。我们的数据表明,CCP2结构域的天然构象对于Ad35结合至关重要,并且在第130至135位或152至156位氨基酸的替换会完全消除CD46的受体功能。这些区域定位于CD46的同一平面表面,并且可能形成一个扩展的腺病毒结合表面,因为这些区域内没有单个氨基酸替换会消除病毒结合。最后,我们证明,具有人类B组血清型Ad11纤维的病毒感染也由CCP2结构域介导。该信息对于更好地描述腺病毒相对于其他与CD46相互作用的病原体的受体识别机制很重要,并且可能有助于设计针对以CD46作为主要细胞附着受体的腺病毒血清型的抗病毒疗法。

相似文献

10
Adenovirus type 11 uses CD46 as a cellular receptor.11型腺病毒将CD46用作细胞受体。
J Virol. 2003 Sep;77(17):9183-91. doi: 10.1128/jvi.77.17.9183-9191.2003.

引用本文的文献

4
Role of Gene Therapy in Pancreatic Cancer-A Review.基因治疗在胰腺癌中的作用——综述
Cancers (Basel). 2018 Apr 3;10(4):103. doi: 10.3390/cancers10040103.
7
Oncolytic virus therapy for cancer.癌症的溶瘤病毒疗法
Oncolytic Virother. 2013 Sep 23;2:31-46. doi: 10.2147/OV.S38901. eCollection 2013.

本文引用的文献

8
CD46 is a cellular receptor for group B adenoviruses.CD46是B组腺病毒的细胞受体。
Nat Med. 2003 Nov;9(11):1408-12. doi: 10.1038/nm952. Epub 2003 Oct 19.
9
Adenovirus type 11 uses CD46 as a cellular receptor.11型腺病毒将CD46用作细胞受体。
J Virol. 2003 Sep;77(17):9183-91. doi: 10.1128/jvi.77.17.9183-9191.2003.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验